Bifogade filer
Kurs
+12,12%
Kalender
Est. tid* | ||
2025-07-31 | 07:00 | Kvartalsrapport 2025-Q2 |
2025-05-16 | N/A | X-dag ordinarie utdelning CRBN 0.64 EUR |
2025-05-14 | N/A | Årsstämma |
2025-02-27 | - | Bokslutskommuniké 2024 |
2024-08-08 | - | Kvartalsrapport 2024-Q2 |
2024-05-17 | - | X-dag ordinarie utdelning CRBN 0.61 EUR |
2024-05-15 | - | Årsstämma |
2024-05-02 | - | X-dag bonusutdelning CRBN 0.1 |
2024-03-01 | - | Bokslutskommuniké 2023 |
2023-08-10 | - | Kvartalsrapport 2023-Q2 |
2023-05-19 | - | X-dag ordinarie utdelning CRBN 0.56 EUR |
2023-05-17 | - | Årsstämma |
2023-03-03 | - | Bokslutskommuniké 2022 |
2022-08-10 | - | Kvartalsrapport 2022-Q2 |
2022-07-05 | - | Extra Bolagsstämma |
2022-05-20 | - | X-dag ordinarie utdelning CRBN 0.56 EUR |
2022-05-18 | - | Årsstämma |
2022-02-25 | - | Bokslutskommuniké 2021 |
2021-10-27 | - | Kvartalsrapport 2021-Q3 |
2021-07-20 | - | Kvartalsrapport 2021-Q2 |
2021-05-21 | - | X-dag ordinarie utdelning CRBN 0.56 EUR |
2021-05-19 | - | Årsstämma |
2021-04-30 | - | Kvartalsrapport 2021-Q1 |
2021-03-05 | - | Bokslutskommuniké 2020 |
2020-10-12 | - | Kvartalsrapport 2020-Q3 |
2020-07-17 | - | Kvartalsrapport 2020-Q2 |
2020-07-01 | - | X-dag ordinarie utdelning CRBN 0.56 EUR |
2020-06-29 | - | Årsstämma |
2020-04-30 | - | Kvartalsrapport 2020-Q1 |
2020-01-13 | - | Bokslutskommuniké 2019 |
2019-11-01 | - | Kvartalsrapport 2019-Q3 |
2019-08-07 | - | Kvartalsrapport 2019-Q2 |
2019-08-05 | - | Extra Bolagsstämma |
2019-04-26 | - | Kvartalsrapport 2019-Q1 |
Corbion, the Amsterdam-listed sustainable ingredients company dedicated to preserving what matters, specializing in lactic acid, lactic acid derivatives, food preservation solutions, functional blends, and algae ingredients, today issued the following statement regarding public statements made by Inclusive Capital Partners, L.P. (“Inclusive”):
The Supervisory Board and Management of Corbion value open dialogue with shareholders and welcome their constructive input. We have engaged, and will continue to engage, with Inclusive in a manner consistent with that approach. We remain focused on delivering long-term value to our shareholders and stakeholders, will continue to take actions to achieve that objective and will consider Inclusive’s suggestions.
As we mentioned in our Q3 Interim Management Statement, we are preparing a restructuring program to manifest itself in 2024. This program includes a full review to drive material improvements in operating expenses, capital program and working capital. Next to this we are conducting a strategic review of Corbion’s position in PLA, developing an Algae Ingredients roadmap 2025-2030 following strong growth prospects, and continuing our focus on our high growth, high value biomedical business. A broader auction process is underway to divest the non-core emulsifier business in order to maximize value.
We are looking forward to presenting our plans on 31st January 2024.